1MJ7 - Header Asymmetric Unit

HEADER IMMUNE SYSTEM 27-AUG-02 1MJ7

TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC TITLE 2 ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG

COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN MS5-393; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT, LIGHT CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: IMMUNOGLOBULIN MS5-393; COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: FAB FRAGMENT, HEAVY CHAIN; COMPND 10 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL_LINE: HYBRIDOMA; SOURCE 6 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 9 OTHER_DETAILS: FUSING OF MOUSE SPLENOCYTES WITH MYELOMA CELL; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 12 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 13 ORGANISM_TAXID: 10090; SOURCE 14 CELL_LINE: HYBRIDOMA; SOURCE 15 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 18 OTHER_DETAILS: FUSING OF MOUSE SPLENOCYTES WITH MYELOMA CELL

KEYWDS CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, KEYWDS 2 IMMUNOGLOBULIN, TSA, IMMUNE SYSTEM

EXPDTA X-RAY DIFFRACTION

AUTHOR S.N.RUZHEINIKOV,T.A.MURANOVA,S.E.SEDELNIKOVA,L.J.PARTRIDGE, AUTHOR 2 G.M.BLACKBURN,I.A.MURRAY,H.KAKINUMA,N.TAKASHI,K.SHIMAZAKI,J.SUN, AUTHOR 3 Y.NISHI,D.W.RICE

REVDAT 3 16-NOV-11 1MJ7 1 VERSN HETATM REVDAT 2 24-FEB-09 1MJ7 1 VERSN REVDAT 1 23-SEP-03 1MJ7 0

JRNL AUTH S.N.RUZHEINIKOV,T.A.MURANOVA,S.E.SEDELNIKOVA,L.J.PARTRIDGE, JRNL AUTH 2 G.M.BLACKBURN,I.A.MURRAY,H.KAKINUMA,N.TAKASHI,K.SHIMAZAKI, JRNL AUTH 3 J.SUN,Y.NISHI,D.W.RICE JRNL TITL HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE FAB-FRAGMENTS OF A JRNL TITL 2 FAMILY OF MOUSE CATALYTIC ANTIBODIES WITH ESTERASE ACTIVITY JRNL REF J.MOL.BIOL. V. 332 423 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12948492 JRNL DOI 10.1016/S0022-2836(03)00902-1

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.A.MURANOVA,S.N.RUZHEINIKOV,S.E.SEDELNIKOVA,A.MOIR, REMARK 1 AUTH 2 L.J.PARTRIDGE,H.KAKINUMA,N.TAKASHI,K.SHIMAZAKI,J.SUN, REMARK 1 AUTH 3 Y.NISHI,D.W.RICE REMARK 1 TITL THE PREPARATION AND CRYSTALLIZATION OF FAB FRAGMENTS OF A REMARK 1 TITL 2 FAMILY OF MOUSE ESTEROLYTIC CATALYTIC ANTIBODIES AND THEIR REMARK 1 TITL 3 COMPLEXES WITH A TRANSITION-STATE ANALOGUE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 57 1192 2001 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444901010149

REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17206 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.303 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 833 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3158 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.51 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 5.371 ; 3.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 6.800 ; 4.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.322 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 8.606 ; 4.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : HAP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1MJ7 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-02. REMARK 100 THE RCSB ID CODE IS RCSB016951.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97800 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17206 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.6 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1MH5 REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, POTASSIUM THIOCYANATE, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.11850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.26550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.11850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.26550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H 319 LIES ON A SPECIAL POSITION.

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS L 214 REMARK 465 GLN H 1 REMARK 465 VAL H 2 REMARK 465 GLN H 3 REMARK 465 LYS H 23 REMARK 465 ALA H 24 REMARK 465 SER H 25 REMARK 465 GLY H 26 REMARK 465 TYR H 27 REMARK 465 THR H 28 REMARK 465 PHE H 29 REMARK 465 THR H 30 REMARK 465 GLY H 53 REMARK 465 SER H 54 REMARK 465 SER H 55 REMARK 465 TYR H 97 REMARK 465 SER H 98 REMARK 465 TRP H 99 REMARK 465 VAL H 129 REMARK 465 CYS H 130 REMARK 465 GLY H 131 REMARK 465 ASP H 132 REMARK 465 THR H 133 REMARK 465 SER H 134 REMARK 465 GLY H 135 REMARK 465 GLY H 229 REMARK 465 PRO H 230 REMARK 465 THR H 231 REMARK 465 ILE H 232 REMARK 465 LYS H 233 REMARK 465 PRO H 234 REMARK 465 CYS H 235 REMARK 465 PRO H 236 REMARK 465 PRO H 237 REMARK 465 CYS H 238 REMARK 465 LYS H 239

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE H 100 CG CD1 CD2 CE1 CE2 CZ

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER L 127 O HOH L 299 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 8 114.35 177.24 REMARK 500 MET L 51 -49.80 66.78 REMARK 500 SER L 67 -142.83 -99.59 REMARK 500 VAL L 78 140.12 -35.21 REMARK 500 TYR L 140 134.59 -170.06 REMARK 500 THR L 200 -3.23 -57.65 REMARK 500 GLN H 43 -167.87 -114.12 REMARK 500 ASN H 65 -57.50 70.14 REMARK 500 SER H 76 72.95 47.85 REMARK 500 SER H 82B 69.02 33.61 REMARK 500 SER H 167 -34.48 -136.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR L 32 0.06 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH H 397 DISTANCE = 5.57 ANGSTROMS REMARK 525 HOH H 418 DISTANCE = 6.92 ANGSTROMS

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HAL H 301

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MIE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC REMARK 900 ANTIBODY MS5-393 REMARK 900 RELATED ID: 1MH5 RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF REMARK 900 THEESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE REMARK 900 ANALOG REMARK 900 RELATED ID: 1MJ8 RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB REMARK 900 FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126 AND A REMARK 900 TRANSITION-STATE ANALOG REMARK 900 RELATED ID: 1MJJ RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB REMARK 900 FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- REMARK 900 STATE ANALOG REMARK 900 RELATED ID: 1MJU RELATED DB: PDB REMARK 900 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX REMARK 900 OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12

REMARK 999 REMARK 999 SEQUENCE REMARK 999 AN APPROPRIATE SEQUENCE DATABASE REFERENCE WAS REMARK 999 NOT AVAILABLE AT THE TIME OF PROCESSING.

DBREF 1MJ7 L 1 214 PDB 1MJ7 1MJ7 1 214 DBREF 1MJ7 H 1 239 PDB 1MJ7 1MJ7 1 239

SEQRES 1 L 219 GLU ILE VAL MET THR GLN ALA ALA PRO SER VAL PRO VAL SEQRES 2 L 219 THR PRO GLY GLU SER VAL SER ILE SER CYS ARG SER SER SEQRES 3 L 219 LYS SER LEU LEU HIS SER ASN GLY ASN THR TYR LEU ASN SEQRES 4 L 219 TRP PHE LEU GLN ARG PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 L 219 ILE TYR ARG MET SER ASN LEU ALA SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLU THR ALA PHE THR LEU SEQRES 7 L 219 ARG THR SER ARG VAL GLU ALA GLU ASP VAL GLY VAL TYR SEQRES 8 L 219 TYR CYS MET GLN HIS LEU GLU TYR PRO PHE THR PHE GLY SEQRES 9 L 219 SER GLY THR LYS LEU GLU LEU LYS ARG ALA ASP ALA ALA SEQRES 10 L 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 228 GLN VAL GLN LEU GLN GLN PRO GLY ALA GLU LEU VAL LYS SEQRES 2 H 228 PRO GLY ALA SER VAL LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 H 228 TYR THR PHE THR SER SER TRP ILE ASN TRP VAL LYS GLN SEQRES 4 H 228 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY ASN VAL TYR SEQRES 5 H 228 PRO GLY SER SER SER THR ASN TYR ASN GLU LYS PHE LYS SEQRES 6 H 228 ASN LYS ALA THR LEU THR VAL ASP THR SER SER SER THR SEQRES 7 H 228 ALA TYR MET GLN LEU SER SER LEU THR SER ASP ASP SER SEQRES 8 H 228 ALA PHE TYR TYR CYS VAL ARG LYS ASP TYR SER TRP PHE SEQRES 9 H 228 PRO TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER ALA SEQRES 10 H 228 ALA LYS THR THR ALA PRO SER VAL TYR PRO LEU ALA PRO SEQRES 11 H 228 VAL CYS GLY ASP THR SER GLY SER SER VAL THR LEU GLY SEQRES 12 H 228 CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR LEU SEQRES 13 H 228 THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS THR SEQRES 14 H 228 PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SER SEQRES 15 H 228 SER SER VAL THR VAL THR SER SER THR TRP PRO SER GLN SEQRES 16 H 228 SER ILE THR CYS ASN VAL ALA HIS PRO ALA SER SER THR SEQRES 17 H 228 LYS VAL ASP LYS LYS ILE GLU PRO ARG GLY PRO THR ILE SEQRES 18 H 228 LYS PRO CYS PRO PRO CYS LYS

HET HAL H 301 33

HETNAM HAL N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}- HETNAM 2 HAL HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE

FORMUL 3 HAL C23 H29 N2 O7 P FORMUL 4 HOH *214(H2 O)

HELIX 1 1 GLU L 79 VAL L 83 5 5 HELIX 2 2 SER L 121 THR L 126 1 6 HELIX 3 3 LYS L 183 GLU L 187 1 5 HELIX 4 4 GLU H 61 LYS H 64 5 4 HELIX 5 5 THR H 83 SER H 87 5 5 HELIX 6 6 SER H 163 SER H 165 5 3 HELIX 7 7 SER H 196 TRP H 199 5 3

SHEET 1 A 4 MET L 4 THR L 5 0 SHEET 2 A 4 VAL L 19 SER L 25 -1 O ARG L 24 N THR L 5 SHEET 3 A 4 ALA L 70 THR L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 A 4 PHE L 62 GLY L 66 -1 N SER L 65 O THR L 72 SHEET 1 B 5 ASN L 53 LEU L 54 0 SHEET 2 B 5 GLN L 45 TYR L 49 -1 N TYR L 49 O ASN L 53 SHEET 3 B 5 LEU L 33 GLN L 38 -1 N LEU L 37 O GLN L 45 SHEET 4 B 5 GLY L 84 GLN L 90 -1 O TYR L 87 N PHE L 36 SHEET 5 B 5 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 C 6 ASN L 53 LEU L 54 0 SHEET 2 C 6 GLN L 45 TYR L 49 -1 N TYR L 49 O ASN L 53 SHEET 3 C 6 LEU L 33 GLN L 38 -1 N LEU L 37 O GLN L 45 SHEET 4 C 6 GLY L 84 GLN L 90 -1 O TYR L 87 N PHE L 36 SHEET 5 C 6 THR L 102 LEU L 106 -1 O LEU L 104 N GLY L 84 SHEET 6 C 6 SER L 10 VAL L 13 1 N VAL L 11 O GLU L 105 SHEET 1 D 4 THR L 114 PHE L 118 0 SHEET 2 D 4 GLY L 129 PHE L 139 -1 O PHE L 135 N SER L 116 SHEET 3 D 4 TYR L 173 THR L 182 -1 O LEU L 179 N VAL L 132 SHEET 4 D 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 E 4 SER L 153 ARG L 155 0 SHEET 2 E 4 ASN L 145 ILE L 150 -1 N ILE L 150 O SER L 153 SHEET 3 E 4 SER L 191 THR L 197 -1 O THR L 197 N ASN L 145 SHEET 4 E 4 ILE L 205 ASN L 210 -1 O ILE L 205 N ALA L 196 SHEET 1 F 5 THR H 57 TYR H 59 0 SHEET 2 F 5 GLU H 46 VAL H 51 -1 N ASN H 50 O ASN H 58 SHEET 3 F 5 TRP H 33 GLN H 39 -1 N ILE H 34 O VAL H 51 SHEET 4 F 5 ALA H 88 LYS H 95 -1 O PHE H 89 N GLN H 39 SHEET 5 F 5 TYR H 102 TRP H 103 -1 O TYR H 102 N ARG H 94 SHEET 1 G 6 THR H 57 TYR H 59 0 SHEET 2 G 6 GLU H 46 VAL H 51 -1 N ASN H 50 O ASN H 58 SHEET 3 G 6 TRP H 33 GLN H 39 -1 N ILE H 34 O VAL H 51 SHEET 4 G 6 ALA H 88 LYS H 95 -1 O PHE H 89 N GLN H 39 SHEET 5 G 6 THR H 107 VAL H 111 -1 O THR H 107 N TYR H 90 SHEET 6 G 6 ALA H 9 VAL H 12 1 N GLU H 10 O THR H 110 SHEET 1 H 3 VAL H 18 SER H 21 0 SHEET 2 H 3 THR H 77 LEU H 82 -1 O MET H 80 N LEU H 20 SHEET 3 H 3 ALA H 67 ASP H 72 -1 N THR H 70 O TYR H 79 SHEET 1 I 4 SER H 120 LEU H 124 0 SHEET 2 I 4 SER H 137 TYR H 147 -1 O LEU H 143 N TYR H 122 SHEET 3 I 4 LEU H 184 THR H 194 -1 O LEU H 187 N VAL H 144 SHEET 4 I 4 VAL H 171 GLN H 179 -1 N HIS H 172 O SER H 190 SHEET 1 J 3 THR H 153 TRP H 158 0 SHEET 2 J 3 THR H 206 HIS H 212 -1 O ASN H 209 N THR H 157 SHEET 3 J 3 THR H 217 LYS H 222 -1 O VAL H 219 N VAL H 210

SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.05 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 4 CYS H 142 CYS H 208 1555 1555 2.04

CISPEP 1 TYR L 94 PRO L 95 0 -0.20 CISPEP 2 TYR L 140 PRO L 141 0 0.47 CISPEP 3 PHE H 148 PRO H 149 0 -0.21 CISPEP 4 GLU H 150 PRO H 151 0 -0.10 CISPEP 5 TRP H 199 PRO H 200 0 0.17

SITE 1 AC1 11 TRP H 33 ASN H 35 ASN H 50 VAL H 93 SITE 2 AC1 11 LYS H 95 TRP H 103 TYR L 32 HIS L 91 SITE 3 AC1 11 LEU L 92 TYR L 94 PHE L 96

CRYST1 128.237 40.531 85.903 90.00 109.72 90.00 C 1 2 1 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.007798 0.000000 0.002795 0.00000

SCALE2 0.000000 0.024672 0.000000 0.00000

SCALE3 0.000000 0.000000 0.012366 0.00000